Pfizer submits initial trial data to FDA for COVID-19 vaccine booster
Pfizer and BioNTech have submitted initial clinical trial data for their joint COVID-19 vaccine booster shot to the U.S. Food and Drug Administration. Pfizer and BioNTech submitted initial clinical trial data of a third COVID-19 vaccine shot to the FDA. Pictured: A nurse prepares a shot of the Pfizer vaccine, August 2021 Pfizer's booster shot showed increased effectiveness against the Indian 'Delta' variant in clinical trials 'Vaccination is our most effective means of preventing COVID-19 infection – especially severe disease and hospitalization – and its profound impact on protecting lives is indisputable,' said Pfizer CEO Albert Bourla in a statement. 'This is why we aim to expand access to our vaccine for people around the world and are working on various approaches as part of our comprehensive strategy to address the virus and its variants today as well as in the future,' 'This initial data indicate that we may preserve and even exceed the high levels of protection against the wild-type virus and relevant variants using a third dose of our vaccine.
An FDA panel meets about which COVID strains the U.S. will target with vaccines
Covid: Third dose can reduce coronavirus-linked deaths by 90%, new study shows
Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey
Discover Related
Most Dutch people have no regrets about coronavirus vaccine
Trump administration cancels FDA vaccine advisory meeting amid flu season concerns
Advances in vaccine technology and the road ahead
What is the cancer vaccine Russia is offering? | Explained
Govt to collate journey of U-WIN so far to overcome challenges
Mixed lessons from intentionally infecting people with COVID-19
5 things we know and still don't know about COVID, 5 years after it appeared
5 things we know and still don't know about COVID, 5 years after it appeared
I’m an Emergency Physician Keeping an Eye on Bird Flu. It’s Getting Dicey.
Wondering If It's Too Late To Get A COVID Vaccine Before Thanksgiving? Read This.
Revealed: The common medications that make your flu shot less effective
State's health department is banned from giving out COVID vaccines
Norovirus vaccine: What is it, when could it be available and will it be on the NHS?
India's New Online Vaccine Portal: A Game Changer for Immunisation Coverage
People 50 and older should get pneumococcal vaccine, US science panel recommends
Global Pandemic Threat: 100 Days to Save Lives
Required vaccine coverage among US kindergartners dips again, new CDC data shows